|
Post by mnkdfann on Dec 7, 2020 17:31:22 GMT -5
MannKind purchased all of the outstanding capital stock of QrumPharma for consideration consisting of $3.5 million in cash and 3,067,179 shares of MannKind common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, net working capital, and other liabilities of QrumPharma. In addition, the selling stockholders of QrumPharma will be entitled to contingent payments in the event that products based on QrumPharma’s intellectual property generate net sales that exceed specified thresholds. Locust Walk served as an advisor to MannKind. How convenient that the MNKD share price ran up recently. Had it been lower when the deal was struck (like it was a month or two ago), presumably QrumPharma would have demanded more shares. A million dollars saved here, a million there, I guess it adds up.
|
|
|
Post by mnkdfann on Dec 7, 2020 12:54:59 GMT -5
In my experience, Zoominfo isn't a great source for accurate information on small companies. I have a friend who owns a small (20-year old) company, and zoominfo is off by a factor of 10 in its reporting of how many employees it has. IMO, I can't help but think if Qrumpharma had anything close to 18 (especially full-time) employees, more than 3 would be listed as such on LinkedIn.
|
|
|
Post by mnkdfann on Dec 7, 2020 12:00:33 GMT -5
Reprtedly 18 - I would guess 4-6 come over How many employees does Qrum have? Mnkd spent $3M plus $9M in stock plus a bunch of extra salaries. If Matt likes it I guess I'm okay with it too. Where did you find 18? Source/link? A search for QrumPharma on LinkedIn says 1-10, only lists 3, and at least 1 of those is part-time (i.e. given they have a full-time hospital job as well). www.linkedin.com/search/results/all/?keywords=Qrumpharma%20Inc. The QrumPharma LinkedIn page itself, says 0-1 (clearly not up to date, but a far cry from 18). www.linkedin.com/company/aumapharma-llc/Q's Senior Scientist graduated with his PhD fairly recently, in 2017, from The University of Western Ontario (in Canada). Go Mustangs! www.linkedin.com/in/brandon-banaschewski-1a163aaa/As you can see at a link above, QrumPharma still refers to itself as Aumapharma. The Visit Website link at the QrumPharma page still takes you to: www.aumapharma.com
|
|
|
Post by mnkdfann on Dec 3, 2020 16:05:27 GMT -5
Two New MannKind Trademarks ... Possible new marketing campaign? 🙂 That reminds me, are these guys still on the payroll?
|
|
|
Post by mnkdfann on Nov 30, 2020 14:39:22 GMT -5
"she has led the operations and exits of several companies" Hmmm. The texts in "(sold to NASDAQ: EDMC), Premier Business Bank (sold to NASDAQ: FFWM)" I wonder if she will help preparation to sell Mannkind. ( ?) "operations and exits of several companies including The Art Institute of Hollywood (sold to NASDAQ: EDMC), Premier Business Bank (sold to NASDAQ: FFWM), Fashion Umbrella, Fremont College, and Dale Carnegie of Los Angeles." FWIW, Wikipedia says Kay founded The Art Institute of Hollywood. EDMC now trades for less than a cent. One share of MNKD will buy you about 2600 shares of EDMC.
|
|
|
Post by mnkdfann on Nov 25, 2020 11:24:21 GMT -5
Not at home anymore. One computer. By memory and StockCharts Multiple patterns on MNKD now. joeypotsandpans and all can you all post charts on multiple time frames please. ... I am looking at this blind, secondary to Spencers POS posted on stockwitts. Spencer is looking for a top. Through this $3.10 which seems a bit insurmountable, $3.30 the Sanofi low, $3.60 the downtrend line from the 2016 top. $4.06. I hope the asshole is wrong. The chart, what I can see of it still looks good to go. Peppy, I'm on the road with phone so doing charts and uploading is not going to happen LOL!! Also, someone should ask Spencer how his YGYI long play he touted and wrote about is doing 🤷♂️, I thought he disappeared, guess not, speaking of Turkeys ......Happy Thanksgiving all!!! 🦃🦃🦃 😉 Love him or hate him, Spencer was right about a lot of things. But I could never understand how such a seemingly bright guy could promote YGYI (Youngevity). To my eyes, it was always obviously a multilevel marketing scam.
|
|
|
Post by mnkdfann on Nov 23, 2020 20:58:43 GMT -5
Cash and cash equivalents of $52.4 million at September 30, 2020 +12.5M milestone payment +20-50M (numbers are my own guess) factory sale/leaseback -? payback of MidCap loan (how much does MNKD have borrowed? I put it at $50M, and the company is required to have $40M in reserve) in order to do the sale/leaseback. $10M burn every Quarter in 2020. Yes, they have really tightened the belt from when we were TV advertising Afrezza and burning ~9M/month Trep-T manufacturing revenue will precede royalties I don't see dilution happening outside of using the ATM Just to daydream a little, go to Yahoo! Finance and click on “Statistics” for PLUG. Yes, it’s fuel cell technology, but: - PLUG’s market cap has gone from $650 million to $10 billion in fourteen months. - Its still losing money so no P/E ratio - 400 million shares outstanding, with 17% short Yes, they have lots more cash and much bigger revenues, but it shows how fast a market cap can explode when the narrative changes. <<sigh>> I agree with everything you say about the narrative. And sentiment and momentum are powerful forces. Even so, I find it interesting that many long term PLUG investors are STILL majorly underwater. PLUG was over $1000 a share at one point.
|
|
|
Post by mnkdfann on Nov 23, 2020 20:54:03 GMT -5
I think you are giving the targeted readership of that newsletter way too much credit. They are not likely to care what Castagna said, or parse what he meant. As sports wrote in the thread, "It’s a penny stock article which means it went out to the boiler rooms." They'll target novice and/or naive investors, who don't know the first thing (and frankly don't care to know) about inhaled insulin or TreT. So I get that but those are still Castagna quotes are they not? So what the hell is talking about. Nothing in my mind. Well, I don't know. Presumably Castagna's words appear in one of the recent transcripts (which are available at Seeking Alpha). I guess the discussion in those may shed some light on what he was talking about. I'm not motivated enough to dig 'em out right now.
|
|
|
Post by mnkdfann on Nov 23, 2020 17:34:42 GMT -5
Did you miss this (be sure to read more than the first post or two): mnkd.proboards.com/thread/12349/penny-stocks-buy So we know someone paid money to that newsletter to hopefully goose the MNKD share price. Who and why, those are the questions. Coincidentally (imo), that came out the same week the Pfizer vaccine news gave a boost to the markets overall, followed shortly after by Moderna, and now AstroZeneca. Right now, it looks like the markets are in melt-up mode. I think the test will be how MNKD reacts once the vaccine euphoria wanes a bit. I saw that but didn't get what Castagna was talking about......"our focus remains on two significant drivers of value for shareholders: enabling healthcare providers to increase their prescribing of Afrezza" (how?) I get the Treprostinil part that followed but I also didn't understand this....."The company plans to expand the Afrezza commercial and medical teams." What does that mean? It sounded like platitudes to me but perhaps I am just so soured on his performance that I dismissed it. So is he hiring more sales people? what does that second comment refer to? I think you are giving the targeted readership of that newsletter way too much credit. They are not likely to care what Castagna said, or parse what he meant. As sports wrote in the thread, "It’s a penny stock article which means it went out to the boiler rooms." They'll target novice and/or naive investors, who don't know the first thing (and frankly don't care to know) about inhaled insulin or TreT.
|
|
|
Post by mnkdfann on Nov 23, 2020 15:04:36 GMT -5
Do you think MNKD had anything to do with the article? If not, I welcome more people knowing about the company. It's paid content and it's all laid out in the disclaimer ( pennystocks.com/disclaimer/) which is refreshingly honest! Hmm. Would a group of investors, like those on a message board, be allowed to purchase a write up in a newsletter like that? Just wondering.
|
|
|
Post by mnkdfann on Nov 23, 2020 14:05:10 GMT -5
Ok, so we continue to see a rate of increase in the share price that is quite out of character for Mannkind. Sure, they recently received the milestone payment from UTHR which should have been baked in. However, we are still facing the prospect of dilution coming up soon so what is driving this share price? Don't get me wrong I think it is great, I just wonder what is behind it. Without some plausible explanation I fear it may retreat at an even faster rate than the increase. So if we could leave aside any unrelated comments, I would like to see legitimate ideas on what has changed. Why now? If, as a group we can't put our finger on it then that says something as well. Did you miss this (be sure to read more than the first post or two): mnkd.proboards.com/thread/12349/penny-stocks-buy So we know someone paid money to that newsletter to hopefully goose the MNKD share price. Who and why, those are the questions. Coincidentally (imo), that came out the same week the Pfizer vaccine news gave a boost to the markets overall, followed shortly after by Moderna, and now AstroZeneca. Right now, it looks like the markets are in melt-up mode. I think the test will be how MNKD reacts once the vaccine euphoria wanes a bit.
|
|
|
Post by mnkdfann on Nov 21, 2020 15:28:19 GMT -5
BTW, I also mentioned to those people at the VA that Afrezza doesn't have to be refrigerated ... and that someone once dug a hole in his yard and stuck a box of Afrezza in it for a few months. When he dug it up it was fine. For 1000s of years, people have been burying food (and more) / sticking it in root cellars to keep it cool and preserve it. Basically, your someone was refrigerating, old school style.
|
|
|
Post by mnkdfann on Nov 21, 2020 14:54:10 GMT -5
|
|
|
Post by mnkdfann on Nov 21, 2020 0:56:41 GMT -5
The video is very clearly edited. It would be nice to hear his complete sentences, and the context of what he said. I suppose you may disagree, but the site 'Collective Evolution' also appears to be rather, shall we say, 'out there'. I question the spin it is putting on Gates' words. Having said all that, I feel sure Gates IS worried about a next pandemic. Many scientists are on the record as saying worse are likely in may of our lifetimes (e.g. within 20 to 30 years, say). (I can't cite names, I'm just going from my memory of various articles I've read.)
|
|
|
Post by mnkdfann on Nov 17, 2020 15:59:39 GMT -5
|
|